Laura Vangeel
Papers
1
Total Citations
14
H-Index
1
About
Laura Vangeel is a virologist whose work sits at the critical intersection of antiviral drug discovery and assay development. Her most impactful contribution to date is the creation of a robust, dual-reporter high-throughput screening (HTS) assay for SARS-CoV-2, a tool designed to accelerate the search for effective treatments during the pandemic. This fully automated assay, detailed in her 2022 paper (14 citations), enables researchers to rapidly and reliably test thousands of compounds for antiviral activity, bypassing the bottlenecks of traditional live-virus methods. By providing a convenient and scalable platform, Vangeel’s work has directly empowered the global effort to identify new antivirals, demonstrating her skill in translating complex virological challenges into practical, high-impact solutions. Her research exemplifies how methodological innovation can be as vital as the discovery itself, offering a powerful tool for future pandemic preparedness and antiviral research.
Research Focus
Key Achievements
Top Papers
- 1